Omnicare — Investor Day (December 2012)
128 slides from Omnicare's investor day presentation, Dec 7, 2012
Slide 1: Omnicare
Omnicare
Slide 2: Forward-Looking Statements
Forward-Looking Statements Certain of th y and listed within fe rd-looking the f the Private S ities Litigation Reform Act of 1995. These forward-looking statements include, but: are not limited to, all statements ae the intent, Pallet or y current expectations Sucl id Ive k a theo ne ReTenee contin
Slide 3: John L. Workman
John L. Workman Analyst Day 2012 Chief Executive Officer
Slide 4: Management Presenters
Management Presenters John Workman [ Chief Executive Officer Nitin Sahney President and Chief Operating Officer Chief Financial Officer Rocky Kraft [ ] [ Senior Vice President, Clinical Services } [ * Senior Vice President, Sales and Marketin Long-Term Care Group David Hileman Senior Vice President,
Slide 5: Today's Objectives
Today’s Objectives Analyst Day 2012
Slide 6: Today's Objectives
Today’s Objectives Strategic overview Operating priorities Long-Term Care Group update — Multi-phased plan — Sales strategy Specialty Care Group overview — Operational insights — Specialty market opportunities Financial review Future drivers Question & answer session Roundtable discussion lunch with
Slide 7: Creating Value
Creating Value Analyst Day 2012
Slide 8: Slide 8
Slide 9: Industry and Market Growth Dynamics
fe Omnicare Industry and Market Analyst Day 2012 Growth Dynamics
Slide 10: Healthcare Trends
Healthcare Trends Aging Population Shaping US Healthcare System‘) 450,000,000 425,000,000 400,000,000 375,000,000 350,000,000 1.5% CAGR US. Population 325,000,000 300,000,000 0.4% CAGR in ) 275,000,000 250,000,000 Seniors’ utilization of pharmaceuticals is more thai three times higher than the gener
Slide 11: Healthcare Trends
Healthcare Trends Healthcare Costs Outpacing Gross Domestic Product Federal healthcare spending as percentage of GDP increased from 2.2% in 1985 to 5.5% in 2011"), primarily driven by: — Increase in healthcare utilization — Major medical advancements that improve the quality of patient care — Increa
Slide 12: Healthcare Trends
Healthcare Trends Companies with Scale Best Positioned in Changing Landscape Healthcare company performance to be driven by volume growth and increased efficiency Government regulations and reimbursement policies expected to incentivize healthcare companies to become more efficient Current Industry
Slide 13: Healthcare Trends
Healthcare Trends New Generic Drug Introductions to Continue Improving Cost Trend * Omnicare has the largest generic drug volume in the long-term care channel; scale enables us to be the only company to source generics direct * New generic introductions expected to be source of efficiencies, though
Slide 14: Healthcare Trends
Healthcare Trends Optimizing the Generic Drug Opportunity Omnicare’s Generic Conversion Rate Advantage Example” 100% 90% 80% 70% 60% 50% 40% 30% 20% Week 1 Week 2 Week 3 Week 4 Week 5 mOCR Average = LTC Industry Average Omnicare’s speed to generic conversion benefits customers, and will be increasin
Slide 15: Healthcare Trends
Healthcare Trends Generic Volumes Expected to Continue Increasing Trend Projected Omnicare Generic Dispensing Rate) 92% 91% 90% = 88.7% 88% 87% 86. 86% aa 85% 84.5% 24% 83.5% — 83% 82% 2012 2013 2014 2015 2016 Omnicare’s speed to generic conversion benefits customers, and will be increasingly critic
Slide 16: Healthcare Trends
Healthcare Trends i Typical Lifecycle of a Nonexclusive Generic Drug Generic Launch Date Gross Profit Time = Branded Drug ™Generic Drug Even after five years, greater than 90% of generic drugs are more profitable than their branded equivalents SET eyed YP ommicare Analyst Day 2012
Slide 17: Senior Care Delivery Market Trends
Senior Care Delivery Market Trends Senior Housing Occupancy on the Rise Senior Housing Occupancy Trends“) While senior housing census has nearly fully recovered since the recession, skilled nursing occupancy remains challenged YP ommicare Analyst Day 2012
Slide 18: Senior Housing Market Trends
Senior Housing Market Trends SNFs Continuing to Evolve Into Post-Acute Spectrum ‘SNF Average Staff Hours per Day”) Average Resident ADL Dependence’) ‘Average Hours Per Patient Day (HPD) ‘Average Resident ADL Dependence ‘2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 ‘20022003 2004 2005 2006
Slide 19: Senior Housing Market Trends
Senior Housing Market Trends Omnicare Well Positioned to Assist SNF Penetration into Post-Acute Market Omnicare services enable our customers to actively target the post-acute market — Omniview + Pre-admission assessment + Discharge processing — Medication availability solutions * Automation + Omniv
Slide 20: Senior Housing Market Trends
Senior Housing Market Trends Focus on Growing Assisted Living Market * Assisted Living Communities — Customized programs targeted at assisted living market — Three-pronged growth opportunity Assisted Living Opportunity Increase Expand r Panaraoninate Grow with Industry YP ommicare Analyst Day 2012
Slide 21: Specialty Pharmaceutical Market Trends
Specialty Pharmaceutical Market Trends Continued Growth for the Foreseeable Future) US Drug Spend Market Share — US Drug Spend Market Share — 2011 2016 => "Traditional Drugs = Specialty Drugs "Traditional Drugs = Specialty Drugs Specialty drug market continues to grow rapidly through increased utili
Slide 22: Specialty Pharmaceutical Market Trends
Specialty Pharmaceutical Market Trends Pharmaceutical Pipeline Abundant with Specialty Products) Marketed & Approved Products Pipeline Products Specialty Drugs 8% Specialty Drugs 42% Traditional Drugs 92% — Traditional Drugs 58% 0% 25% 50% 75% 100% 0% 20% «40% 60% 80% Market Share Share of Developme
Slide 23: Operating Priorities
Operating Priorities Analyst Day 2012
Slide 24: Leveraging Omnicare's Assets
Leveraging Omnicare’s Assets Focus on Three Priorities YP ommicare Analyst Day 2012
Slide 25: Establishing Consistent Organic Growth in LTC
Leveraging Omnicare’s Assets Establishing Consistent Organic Growth in LTC — Three Factors Controllable Uncontrollable Beds Utilization Census Acuity Length zee of Si) Sales Facility Utilization Type Levels Scripts are the leading barometer for revenue growth; beds represent the aspect of scripts we
Slide 26: Establishing Consistent Organic Growth in LTC
' Leveraging Omnicare’s Assets Establishing Consistent Organic Growth in LTC. * Controllable organic growth dependent on... Retention Understand market opportunities Align value proposition to market needs + Operational excellence initiatives to drive service improvements + Expanded technology Defin
Slide 27: Continuing SCG Growth Momentum
Leveraging Omnicare’s Assets Continuing SGC Growth Momentum "Revenue mms Revenues —-Adjusted Operating Profit'?) Operating Profit | ensmitos ‘ns miton) $950.0 | 35,0 52000 00 5 $2500 $250 $200.0 $20.0 $150.0 $15.0 | / $100.0 00
Slide 28: Continuing SCG Growth Momentum — Focus on Fee-for-Service
Leveraging Omnicare’s Assets Continuing SGC Growth Momentum — Focus on Fee-for-Service We believe Omnicare’s end-to-end commercialization solution resonates with clients Specialty drugs account for a significant portion of ’ the drug development pipeline BioPharma continuing to move towards strategi
Slide 29: Continuing SCG Growth Momentum — Focus on Fee-for-Service
Leveraging Omnicare’s Assets Continuing SGC Growth Momentum — Focus on Fee-for-Service Growth Opportunities _ New Products Fee-for-service business brings the additional benefit of payer diversity jue! Bunsixy YP ommicare Analyst Day 2012
Slide 30: Continuing SCG Growth Momentum
Leveraging Omnicare’s Assets Continuing SGC Growth Momentum Having both businesses under one management team improves coordination and creates collaborative opportunities — Xenazine exclusive provider agreement — Private label specialty pharmacy opportunities SCG sales structure only operational for
Slide 31: Capital Allocation
Efficiently Leveraging Omnicare’s Assets Capital Allocation * Targeting 50% of cash flows from operations“) returned to shareholders * Three-year track record of returning capital to shareholders — Increased dividend four times and over 500% since July 2010 ($0.56 /share/yr) — Approved four share re
Slide 32: Slide 32
Slide 33: Nitin Sahney
Nitin Sahney Analyst Day 2012 President & Chief Operating Officer
Slide 34: Long-Term Care Group / Specialty Care Group
Long-Term Care Group Specialty Care Group Business : Overview i Customers Market y Position Annual Prescriptions ‘commercialization services business,
Slide 35: Omnicare's Primary Businesses By the Numbers
Omnicare’s Primary Businesses By the Numbers LTM 9/30/12 Revenue) LTM 9/30/12 Adjusted Operating Income?) $13.2M Long Term Care Specialty Care = Other Long Term Care s=Specialty Care = Other Omnicare’s primary businesses are well positioned to capitalize on two distinct markets See penx Ext 1 feel o
Slide 36: Long-Term Care Group
Long-Term Care Group Analyst Day 2012
Slide 37: Long-Term Care Market Overview
Long-Term Care Group Long-Term Care Market Overview Monthly Prescripti Customer Primary Competitors per Patient") OCR Market Growth Rate | Market Share , , National providers eae Regional providers 127 -0.3%(2) ~40% Independent providers Retail Pnerac) Assisted Living Mail-o1 Orel ea) Facilities (AL
Slide 38: Core Institutional Pharmacy Value Proposition
Long-Term Care Group Core Institutional Pharmacy Value Proposition Clinical Pharmacy Technology Services Operations Services SNF chart reviews Unit sa medication Faxed new and refill orders Regular point of contact ackaging Payer source verification for customer 24/7 medication delivery to meet admi
Slide 39: Clinical Tools Designed to Improve Quality of Care
Omnicare Clinical Services Clinical Tools Designed to Improve Quality of Care = — Long-Term Care Group YP ommicare Analyst Day 2012 1. Varies by customer, based on Omnicare internal data
Slide 40: Benefits of High Quality Clinical Program
Omnicare Clinical Services Benefits of High Quality Clinical Program Improve patient outcome: Improve Omnicare Lower facility selling effectiveness re-hospitalization rate Programs Improved retention Increase in facility rate for Omnicare census Similar to other healthcare industries, the long-term
Slide 41: Core Institutional Pharmacy Value Proposition
Long-Term Care Group Core Institutional Pharmacy Value Proposition A - —_ Clinical Pharmacy Technology Services Operations Services 8 SNF chart reviews Unit sa medication Faxed new and refill orders 2 Regular point of contact ackaging Payer source verification 8 for customer 24/7 medication delivery
Slide 42: Infrastructure Ensures National Reach
Omnicare Pharmacy Operations Infrastructure Ensures National Reach a if OG \ es, oc 2 P at ® * * * es _ ote ey *. ®. * ® ® we ‘ * Omnicare’s network includes 32 regional hubs and over 120 spoke pharmacy locations YP ommicare Analyst Day 2012
Slide 43: Competitive Advantages of National Network
Omnicare Pharmacy Operations Competitive Advantages of National Network Most extensive pharmacy network for geographically dispersed chains Scalable platform enables Omnicare to redeploy resources to capitalize on local market opportunities Scalable platform provides for more standardization of rout
Slide 44: OCEAN to Create Further Operational Efficiencies
Omnicare Pharmacy Operations OCEAN to Create Further Operational Efficiencies ON NETWORK EEE Current Challenges Solutions \ + Multiple pharmacy operating * One state-of-the-art Oracle systems system » Enhanced data accuracy 30 year-old technology and timeliness for reporting and decision-making Subs
Slide 45: Core Institutional Pharmacy Value Proposition
Long-Term Care Group Core Institutional Pharmacy Value Proposition Clinical macy Services Operations SNF chart reviews Va Technology Services Unit dose tedeaton Faxed new and refill orders packagi Payer source verification = S 3 = a 6 Regular point of contact for customer 24/7 medication —— to meet
Slide 46: Technology Offering Fully Integrated Through Omniview
Omnicare Technology Services Technology Offering Fully Integrated Through Omniview™ Omnicare’s secure web-based worksite for customer facilities, prescribers and patients Classic Omniview OmniviewDr YP ommicare Analyst Day 2012
Slide 47: Future Technology Solutions
Omnicare Technology Services Future Technology Solutions + Deployment of Automation and Customer-Facing Technology — Develop and implement new technology for Pharmacy and In-Facility solutions that provides the following benefits: + Highest accuracy and quality with a validate-able process * Streaml
Slide 48: Using Our Value Proposition to Drive Growth
Using Our Value Proposition to Drive Growth Technology Services Creating Value Clinical Pharmacy Services Operations With the Three Pillars of Omni Value Proposition, we believe we have a differentiated service offering that is aligned with our customers’ needs YP ommicare Analyst Day 2012
Slide 49: Transition to Operations-Driven Company is Underway
Long-Term Care Group Transition to Operations-Driven Company is Underway M&A Operationally Focused Focused YP ommicare Analyst Day 2012
Slide 50: Initial Change from M&A Strategy to Operational Focus
Long-Term Care Group Initial Change from M&A Strategy to Operational Focus * Reorganized from 13 regions to 5 divisions Investments in people — Restoration of salaries — Core values roll-out Executive customer reviews Redeployed retention resources and redefined roles Continued customer-facing techn
Slide 51: Customer Service Improvements
Initial Focus on Long-Term Care Operations Customer Service Improvements Service-Related Bed Loss Trend 2011 m2012 86% of facility customers would Omnicare’s service); Expertise of our consultant pharmacists is the highest rated area of service delivery YP ommicare Analyst Day 2012
Slide 52: Retention Improved but More Progress is Needed
Initial Focus on Long-Term Care Operations Retention Improved but More Progress is Needed 100% 95% 90% + 85% 80% Quarterly Retention Rate Trend) 1Q10 2Q10 3Q10 4Q10 1Q11 2Q11 3Q11 4Q11 1Q12 2Q12 3Q12 —Retention Rate Initial results were encouraging but further progress is required YP ommicare Analys
Slide 53: Investments in Sales Team Did Not Improve Sales Performance
| Initial Focus on Long-Term Care Operations Investments in Sales Team Did Not Improve Sales Performance 20,000 35 15,000 si 10,000 25 New Bed Additions LTC Sales Personnel 5,000 20 4Q10 1011 2011 3011 4aQit 1Q12 2Q12 3Q12 mmm New Bed Adds =—=LTC Sales FTE's YP ommicare Analyst Day 2012
Slide 54: Transition to Operations-Driven Company is Underway
Long-Term Care Group Transition to Operations-Driven Company is Underway M&A Operationally Operational Focused Focused Excellence YP ommicare Analyst Day 2012
Slide 55: Three-Phase Operational Plan
Refining Long-Term Care Focus on Operations Three-Phase Operational Plan Phase 1: IEE S28 First 100 Days Phase 3: Day 101 thru 2013 3Q13 and Beyond Multi-phase plan underway to structurally position Omnicare for consistent organic growth in Long-Term Care YP ommicare Analyst Day 2012
Slide 56: Heightened Focus on the Underperformers
Refining Long-Term Care Focus on Operations Heightened Focus on the Underperformers * Hub performance and retention inconsistent — Six regional service areas significantly underperforming * Opportunity to increase organic growth potential by standardizing operations across all service areas 3Q12 Yea
Slide 57: Redefining our Sales Organization
Refining Long-Term Care Focus on Operations Redefining our Sales Organization Resources not aligned with opportunities — Best sales resources not focused on highest-potential areas Value proposition not communicated consistently Structure not maximizing resources — Rebalance allocation of sales mana
Slide 58: LTC Sales Strategy Overview
Long-Term Care Group LTC Sales Strategy Overview + While certain aspects of customer attrition are uncontrollable, new sales is a component of organic growth which is fully controllable — SNF Growth Rate of -0.3%') * Inadeclining market, growing overall beds requires taking market share — ALF Growth
Slide 59: Senior Vice President, Sales & Marketing, Long-Term Care
rNaalimerlial Senior Vice President, Sales & Marketing, Long-Term Care Operations Analyst Day 2012
Slide 60: Sales Transformation Components
Sales Transformation Components
Slide 61: Action Plan & Timetable for Changes
Long-Term Care Sales Strategy Action Plan & Timetable for Changes Phase 2: Near-term targets (Nov. = Refreshed analysis of 2012 —Jan. 2013) + Launch inside sales program markets to identify high potential regions + Sales structure redefined: focus on high potential & + Sales team training high profi
Slide 62: Goals of Sales Transformation
Long-Term Care Sales Strategy Goals of Sales Transformation Sales transformation is ongoing with longer-term structural changes in development Near-term initiatives driven by maximizing immediate opportunities with current customers Sales transformation will take time to fully materialize Goal is to
Slide 63: Nitin Sahney
Nitin Sahney Analyst Day 2012 President & Chief Operating Officer
Slide 64: Three-Phase Operational Plan
Refining Long-Term Care Focus on Operations Three-Phase Operational Plan Phase 1: Phase 2: Phase 3: First 100 Days Day 101 thru 2Q13 3Q13 and Beyond + Operating discipline + Acton Phase 1 takeaways: Assess the benefits realized — Accountability + Improve clues realign five during Phase 1 - elaborati
Slide 65: Expectations for Three-Phase Plan
Refining Long-Term Care Focus on Operations Expectations for Three-Phase Plan « Upon completion of our operational plan, we expect: — Improved retention — Increased sales Retention Rate Expectations Organic Sales Expectations g E A 92.6% 3 40,737 1 f sare sare Improved sales and consistent customer
Slide 66: Specialty Care Group
Specialty Care Group Analyst Day 2012
Slide 67: Specialty Care Group
Specialty Care Group rc . Omnicare 20:12: Omnicare strategically acquired four companies with extensive experience to leverage synergistic services for manufacturers, providers, payers and patient communities. fe PBM Plus ryA Crossroads <sy4, ACS Founded: 1993 Founded:1985 = Founded: 1996 Founded: 2
Slide 68: Omnicare's Five Operating Platforms
Specialty Care Group Omnicare’s Five Operating Platforms Brand Supply Patient Specialty End of Life Support Chain Support Pharmacy Care Services Solutions Services Third Party Customer Fy Revenue Fee for Service Model Per Diem Model Buy/Sell Model Product Manufacturer owns the product SCG owns the p
Slide 69: David Hileman
David Hileman Analyst Day 2012 Senior Vice President, Specialty Care Group Operations
Slide 70: Market Challenges
Market Challenges i ~~ Se 7 = Payer Governmental Product Utilization management controls A + Prior authorizations + Patient Assistance + Non-broad based channel + Step therapy Programs become strategies more complex in “under-insured” patient populations YP ommicare Analyst Day 2012
Slide 71: Impact Along the Product Path
Impact Along the Product Path Patients Providers Payers Distribution Omnicare’s Specialty Care Group provides an integrated end-to-end solution for manufacturers YP ommicare Analyst Day 2012
Slide 72: Integration Goals
Integration Goals Simplify Provider’s Involvement + Reduce barriers to prescribing + Overcome burdensome processes Engage the Patient + Web-tools + Social Media + Targeted Patient Education + Nurse Counseling Leverage Customized Distribution Capabilities + Direct to physician and patient XN > + — In
Slide 73: Operations Building Success
Operations Building Success + SP Networks * Co-Pay Assistance * Compliance & Adherence * Clinical Management + Reimbursemer + Patient Assi: Management + Web Tools YP ommicare Analyst Day 2012
Slide 74: Integrated Service Example
Integrated Service Example Typical Supply Chain Manufacturer Product Purchased Product Acquired Patient Fills Produces Product by Wholesaler by Pharmacy Prescription Omnicare Manufacturer Patient Fills Specialty Care Group Produces Product Prescription Crossroads » ACS - PBM Plus - excolleFi. Using
Slide 75: Manufacturer-Centric Integrated Support
Manufacturer- tric Independent Adaptable Integrated d Support 60% of customers have more than one program within SCG
Slide 76: Target Customers & Characteristics
Target Customers & Characteristics Fee for Service Specialty Dispensi Brand Support New Networks Patient Assistance Foundation Programs 39 Party Logistics Physician Sales Large Biotech/ Small/Orphan Pharma Biotech * Complex + Virtual + Limited + Enhance * Service driven Organization Organization Con
Slide 77: Typical Deal Characteristics
Typical Deal Characteristics Service Brand Patient 39 Party Type (Es -)felis Assistance Logistics Sales Cycle 3-6 10-15 months days 6-9 month 2-3 months Contract 3 years Ctl 100% since SCG reorganization in 4Q10 100% since SCG reorganization in 4Q10 YP ommicare Analyst Day 2012
Slide 78: Typical Sales Process
Typical Sales Process Process Sales Acti Sales Activity Activities Owner Lead Support * Client mapping Senenitvstemat ' + Research ecutive Team 1. Lead Generation | Nea Sales Team Sales Team Operations + Pro-active selling + Scope Q&A + Solution approach i * Pricing Sales Team CEBe: Sales Team + Pro
Slide 79: Gaining Traction in the Marketplace
Specialty Care Group Gaining Traction in the Marketplace Specialty Care Group Fee for Service RFP Conversion Trend 3Q1t 4Qit 1Q12 2Q12 3Q12 m# Contract Wins m#RFPs xt# RFPs Still in Play Since reorganization of the sales structure, the Specialty Care Group has experienced significant sales improveme
Slide 80: Denise Von Dohren
Denise Von Dohren Analyst Day 2012 Vice President, Access Solutions, Specialty Care Group
Slide 81: Slide 81
Slide 82: Slide 82
Slide 83: Slide 83
Slide 84: Slide 84
Slide 85: Slide 85
Slide 86: Slide 86
Slide 87: Slide 87
Slide 88: Slide 88
Slide 89: Slide 89
Slide 90: Slide 90
Slide 91: Slide 91
Slide 92: Slide 92
Slide 93: Slide 93
Slide 94: Slide 94
Slide 95: Slide 95
Slide 96: Slide 96
Slide 97: Slide 97
Slide 98: Slide 98
Slide 99: Slide 99
Slide 100: Slide 100
Slide 101: Slide 101
Slide 102: Slide 102
Slide 103: Slide 103
Slide 104: Slide 104
Slide 105: Slide 105
Slide 106: Slide 106
Slide 107: Slide 107
Slide 108: Slide 108
Slide 109: Slide 109
Slide 110: Slide 110
Slide 111: Slide 111
Slide 112: Slide 112
Slide 113: Slide 113
Slide 114: Slide 114
Slide 115: Slide 115
Slide 116: Slide 116
Slide 117: Slide 117
Slide 118: Slide 118
Slide 119: Slide 119
Slide 120: Slide 120
Slide 121: Slide 121
Slide 122: Slide 122
Slide 123: Slide 123
Slide 124: Slide 124
Slide 125: Slide 125
Slide 126: Slide 126
Slide 127: Slide 127
Slide 128: Slide 128